Addressing the unmet medical need for safe and effective weight loss therapies

被引:34
作者
Arbeeny, CM [1 ]
机构
[1] Genzyme Drug Discovery & Dev, Waltham, MA 02451 USA
来源
OBESITY RESEARCH | 2004年 / 12卷 / 08期
关键词
weight loss; antiobesity; pharmacotherapy; drug development; metabolic syndrome;
D O I
10.1038/oby.2004.150
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is a significant healthcare problem worldwide and increases the risk of developing debilitating diseases including type 2 diabetes, cardiovascular disease, and cancer. Although the health benefits of weight reduction are well-recognized, weight loss by diet and exercise fail in most patients, and the current marketed drugs have had limited success. It is clear that there is a significant unmet medical need for safe and effective weight-reducing agents. In this review, the current status of potential weight loss approaches that are in development by the pharmaceutical and biotechnology industry are discussed. This should lead to novel treatments that can be used long-term to effectively treat this serious metabolic disorder.
引用
收藏
页码:1191 / 1196
页数:6
相关论文
共 11 条
[1]  
[Anonymous], 2001, The Surgeon Generals call to action to prevent and decrease overweight and obesity
[2]   EFFECT OF DEGREE OF WEIGHT-LOSS BENEFITS [J].
BLACKBURN, G .
OBESITY RESEARCH, 1995, 3 :S211-S216
[3]  
Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256
[4]  
GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397
[5]  
*INT OB TASK FORC, 2004, GLOB EP
[6]   Diabetes trends in the US: 1990-1998 [J].
Mokdad, AH ;
Ford, ES ;
Bowman, BA ;
Nelson, DE ;
Engelgau, MM ;
Vinicor, F ;
Marks, JS .
DIABETES CARE, 2000, 23 (09) :1278-1283
[7]  
MOKDAD AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI DOI 10.1001/JAMA.289.1.76
[8]   Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. [J].
Tuomilehto, J ;
Lindström, J ;
Eriksson, JG ;
Valle, TT ;
Hamalainen, H ;
Ilanne-Parikka, P ;
Keinanen-Kiukaanniemi, S ;
Laakso, M ;
Louheranta, A ;
Rastas, M ;
Salminen, V ;
Uusitupa, M ;
Aunola, S ;
Cepaitis, Z ;
Moltchanov, V ;
Hakumaki, M ;
Mannelin, M ;
Martikkala, V ;
Sundvall, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (18) :1343-1350
[9]  
*US DEP HHS, 2000, NAT I HLTH PUBL
[10]   WEIGHT, WEIGHT CHANGE, AND CORONARY HEART-DISEASE IN WOMEN - RISK WITHIN THE NORMAL-WEIGHT RANGE [J].
WILLETT, WC ;
MANSON, JE ;
STAMPFER, MJ ;
COLDITZ, GA ;
ROSNER, B ;
SPEIZER, FE ;
HENNEKENS, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (06) :461-465